| 000 | 01308 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250511212114.0 | ||
| 264 | 0 | _c19910506 | |
| 008 | 199105s 0 0 eng d | ||
| 022 | _a0022-1899 | ||
| 024 | 7 |
_a10.1093/infdis/163.4.849 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRex, J H | |
| 245 | 0 | 0 |
_aIn vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _cApr 1991 |
||
| 300 |
_a849-52 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAspergillus fumigatus _ximmunology |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aGranulomatous Disease, Chronic _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-gamma _xtherapeutic use |
| 650 | 0 | 4 |
_aNeutrophils _ximmunology |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 700 | 1 | _aBennett, J E | |
| 700 | 1 | _aGallin, J I | |
| 700 | 1 | _aMalech, H L | |
| 700 | 1 | _aDeCarlo, E S | |
| 700 | 1 | _aMelnick, D A | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 163 _gno. 4 _gp. 849-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/infdis/163.4.849 _zAvailable from publisher's website |
| 999 |
_c1907530 _d1907530 |
||